
2025 Three Rivers Otolaryngology Update
Target Audience
Otolaryngologists, primary care physicians, pediatricians, family practitioners, nurse practitioners, physician assistants, residents, audiologists, speech therapists and other interested health care professionals.
Learning Objectives
At the completion of the course, the participant should be able to:
1. Demonstrate an understanding of key principles of global outreach in Otolaryngology
2. Recognize the importance of health equity in the clinical and research aspects of Otolaryngology
3. Describe the emerging research in the field of otology and how this translates into clinical practice
4. Describe recent advances and innovative techniques in laryngology
5. Understand the controversies surrounding complex head and neck cancer care
6. Describe novel techniques for facial plastics and reconstructive surgery
Keynote Speakers:
Johan Fagan, MD
Jennifer Grandis, MD, PhD
Faculty Disclosure:
All individuals in a position to control the content of this education activity have disclosed all financial relationships with any companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All of the relevant financial relationships for the individuals listed below have been mitigated
Peter Santa Maria is a consultant with Medtronic.
Jose Zevallos has grant/research support with Merck. Is a consultant with Johnson & Johnson and Merck. Has privately held stockholder with Droplet Biosciences, Vine Medical, and Echogenesis Therapeutics.
Daniel Faden has grant/research support with BostonGene, Neogenomics, Haystack (Quest), Bristol-Myers Squibb, Calico, and Predicine. He is a consultant with Merck, Noetic, Chrysalis Biomedical Advisors, Neogenomics, Arcadia, and Focus.
Maura Cosetti has grant/research support with Cochlear Americas and MedEL. She is a consultant with Institute for Cochlear Implant Training.
Priya Krishna is a consultant with Smith & Nephew and Stryker.
Nicole Schmitt has grant/research support with Astex Pharmaceuticals/Taiho Oncology. She is a consultant with GeoVax, Regeneron, Johnson and Johnson, Synergy Research, Aspargo Labs, and Sensorion.
Thomas Carroll is a consultant with Pentax Medical, Ambu, and GSK. He is a privately held stockholder with Sofregen Medical and N-Zyme Biomedical.
Philip Perez is a consultant with Gateway Biotechnology, Inc. He is a privately held stockholder with Gateway Biotechnology, Inc.
Libby Smith is a consultant with Advisory Board: INOVIO Pharmaceuticals, Inc.
Matthew Spector is a consultant with Hologic.
No other members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships with any companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician (CME)
The University of Pittsburgh designates this live activity for a maximum of 10.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing (CNE)
The maximum number of hours awarded for this Continuing Nursing Education activity is 10.5 contact hours.
Physician Assistant (AAPA)
The University of Pittsburgh has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 10.5 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.
Available Credit
- 10.50 AAPA Category I CME
- 10.50 AMA PRA Category 1 Credit™The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
- 10.50 ANCCUPMC Provider Unit is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation
- 10.50 Attendance
Thank you to our Exhibitors:
Bryan Medical/Cuesta Medical Solutions
Cochlear Americas
GSK
Johnson & Johnson MedTech
Karl Storz
Maya Medical, Grace Medical, Hemostasis
Merck
Smith & Nephew
Price
Registration fees/categories
Non-UPMC Physicians: $300.00
CENTS/Alumni members: $250.00
UPMC Faculty/Residents/Fellows/Speakers: $0
All cancellations must be in writing and sent to us via U.S. mail, e-mail. Tuition for cancellations postmarked or date stamped before February 28, 2025, will be completely refunded. From February 28-March 7, 2025, a $50.00 administrative fee will be assessed. No refunds will be made after March 7, 2025. “No shows” are not eligible for refunds.
Cancellation requests can be made to:
Janice Schneider
Department of Otolaryngology
[email protected]